2023
1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants
Gillespie M, McElhinney D, Jones T, Levi D, Asnes J, Gray R, Cabalka A, Fujimoto K, Qureshi A, Justino H, Bergersen L, Benson L, Haugan D, Boe B, Cheatham J. 1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants. JACC Cardiovascular Interventions 2023, 16: 1917-1928. PMID: 37278682, DOI: 10.1016/j.jcin.2023.03.002.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valveRight ventricular outflow tractSevere pulmonary regurgitationPulmonary regurgitationPrimary analysisCardiac magnetic resonance imagingContinued Access StudyMild pulmonary regurgitationOne-year safetyMedian patient agePulmonary valve replacementLong-term valve performanceVentricular outflow tractFirst U.S. FoodClinical trial participantsMagnetic resonance imagingEligible patientsMost patientsPatient ageValve replacementHemodynamic outcomesPooled cohortPulmonary valveVentricular tachycardiaClinical indications
2020
Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis
Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, McElhinney DB. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. Journal Of The American College Of Cardiology 2020, 76: 2847-2858. PMID: 33303074, DOI: 10.1016/j.jacc.2020.10.041.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valve replacementPulmonary valve replacementSAPIEN XTValve replacementS3 valveMost patientsShort-term outcome dataGreater pulmonary regurgitationMaximum Doppler gradientOutflow tract anatomyTricuspid valve injurySAPIEN 3 valveSerious adverse eventsBalloon-expandable valveShort-term outcomesSurgical valve replacementValve complicationsMulticenter registryUrgent surgeryAdverse eventsDoppler gradientPulmonary regurgitationSAPIEN prosthesisTotal patientsValve injury
2017
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIV